Zimmer Biomet price target lowered to $112 from $118 at Barclays
Barclays lowered the firm’s price target on Zimmer Biomet (ZBH) to $112 from $118 and keeps an Underweight rating on the shares. The firm ...
Zimmer Biomet Holdings (ZBH) Receives a Buy from BTIG
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...
NeuroOne projects FY 2025 revenue growth of up to 190% with Zimmer Biomet partnership
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...
Becker's Spine Review22h
3 Zimmer Biomet updates to know in 3 weeks
Stay updated on Zimmer Biomet with Becker's as they report on recent updates, including sales growth, a new acquisition, and a successful surgery.
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors
Shares of Zimmer Biomet Holdings Inc. ZBH slipped 1.43% to $98.98 Tuesday, on what proved to be an all-around great trading ...
Barchart on MSN1d
Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink?
Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare ...
Morningstar4d
Zimmer Biomet Holdings Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...